BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 9475094)

  • 21. WT1 and glomerular diseases.
    Niaudet P; Gubler MC
    Pediatr Nephrol; 2006 Nov; 21(11):1653-60. PubMed ID: 16927106
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Frasier syndrome, part of the Denys Drash continuum or simply a WT1 gene associated disorder of intersex and nephropathy?
    Koziell A; Charmandari E; Hindmarsh PC; Rees L; Scambler P; Brook CG
    Clin Endocrinol (Oxf); 2000 Apr; 52(4):519-24. PubMed ID: 10762296
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Identification of constitutional WT1 mutations, in patients with isolated diffuse mesangial sclerosis, and analysis of genotype/phenotype correlations by use of a computerized mutation database.
    Jeanpierre C; Denamur E; Henry I; Cabanis MO; Luce S; Cécille A; Elion J; Peuchmaur M; Loirat C; Niaudet P; Gubler MC; Junien C
    Am J Hum Genet; 1998 Apr; 62(4):824-33. PubMed ID: 9529364
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Dominant negative mutations in the Wilms tumour (WT1) gene cause Denys-Drash syndrome--proof that a tumour-suppressor gene plays a crucial role in normal genitourinary development.
    Hastie ND
    Hum Mol Genet; 1992 Aug; 1(5):293-5. PubMed ID: 1338905
    [No Abstract]   [Full Text] [Related]  

  • 25. WT1 interacts with the splicing factor U2AF65 in an isoform-dependent manner and can be incorporated into spliceosomes.
    Davies RC; Calvio C; Bratt E; Larsson SH; Lamond AI; Hastie ND
    Genes Dev; 1998 Oct; 12(20):3217-25. PubMed ID: 9784496
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A Japanese case with Frasier syndrome caused by the splice junction mutation of WT1 gene.
    Okuhara K; Tajima S; Nakae J; Sasaki S; Tochimaru H; Abe S; Fujieda K
    Endocr J; 1999 Oct; 46(5):639-42. PubMed ID: 10670748
    [TBL] [Abstract][Full Text] [Related]  

  • 27. An unusual phenotype of Frasier syndrome due to IVS9 +4C>T mutation in the WT1 gene: predominantly male ambiguous genitalia and absence of gonadal dysgenesis.
    Melo KF; Martin RM; Costa EM; Carvalho FM; Jorge AA; Arnhold IJ; Mendonca BB
    J Clin Endocrinol Metab; 2002 Jun; 87(6):2500-5. PubMed ID: 12050205
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The ratio of +/-KTS splice variants of the Wilms' tumour suppressor protein WT1 mRNA is determined by an intronic enhancer.
    Yang C; Romaniuk PJ
    Biochem Cell Biol; 2008 Aug; 86(4):312-21. PubMed ID: 18756326
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The role of Wilms' tumor genes.
    Hirose M
    J Med Invest; 1999 Aug; 46(3-4):130-40. PubMed ID: 10687307
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Novel familial WT1 read-through mutation associated with Wilms tumor and slow progressive nephropathy.
    Zirn B; Wittmann S; Gessler M
    Am J Kidney Dis; 2005 Jun; 45(6):1100-4. PubMed ID: 15957141
    [TBL] [Abstract][Full Text] [Related]  

  • 31. DNA binding capacity of the WT1 protein is abolished by Denys-Drash syndrome WT1 point mutations.
    Little M; Holmes G; Bickmore W; van Heyningen V; Hastie N; Wainwright B
    Hum Mol Genet; 1995 Mar; 4(3):351-8. PubMed ID: 7795587
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A newly identified exonic mutation of the WT1 gene in a patient with Denys-Drash syndrome.
    Tsuda M; Sakiyama T; Owada M; Chiba Y
    Acta Paediatr Jpn; 1996 Jun; 38(3):265-6. PubMed ID: 8741319
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Role for first zinc finger of WT1 in DNA sequence specificity: Denys-Drash syndrome-associated WT1 mutant in ZF1 enhances affinity for a subset of WT1 binding sites.
    Wang D; Horton JR; Zheng Y; Blumenthal RM; Zhang X; Cheng X
    Nucleic Acids Res; 2018 May; 46(8):3864-3877. PubMed ID: 29294058
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Wilms tumor and the WT1 gene.
    Lee SB; Haber DA
    Exp Cell Res; 2001 Mar; 264(1):74-99. PubMed ID: 11237525
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A girl with bilateral ovarian tumours: Frasier syndrome.
    Shimoyama H; Nakajima M; Naka H; Park YD; Hori K; Morikawa H; Yoshioka A
    Eur J Pediatr; 2002 Feb; 161(2):81-3. PubMed ID: 11954756
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Transcriptional regulation of PDGF-A and TGF-beta by +KTS WT1 deletion mutants and a mutant mimicking Denys-Drash syndrome.
    Jin DK; Kang SJ; Kim SJ; Bang EH; Hwang HZ; Tadokoro K; Yamada M; Kohsaka T
    Ren Fail; 1999 Nov; 21(6):685-94. PubMed ID: 10586431
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Inherited WT1 mutation in Denys-Drash syndrome.
    Coppes MJ; Liefers GJ; Higuchi M; Zinn AB; Balfe JW; Williams BR
    Cancer Res; 1992 Nov; 52(21):6125-8. PubMed ID: 1327525
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Truncated WT1 mutants alter the subnuclear localization of the wild-type protein.
    Englert C; Vidal M; Maheswaran S; Ge Y; Ezzell RM; Isselbacher KJ; Haber DA
    Proc Natl Acad Sci U S A; 1995 Dec; 92(26):11960-4. PubMed ID: 8618823
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Gonad development in Drash and Frasier syndromes depends on WT1 mutations.
    Jaubert F; Vasiliu V; Patey-Mariaud de Serre N; Auber F; Jeanpierre C; Gubler MC; Nihoul-Fékété C; Fellous M
    Arkh Patol; 2003; 65(2):40-4. PubMed ID: 15357247
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Bilateral Wilms tumor in a boy with severe hypospadias and cryptochidism due to a heterozygous mutation in the WT1 gene.
    Köhler B; Schumacher V; Schulte-Overberg U; Biewald W; Lennert T; l'Allemand D; Royer-Pokora B; Grüters A
    Pediatr Res; 1999 Feb; 45(2):187-90. PubMed ID: 10022588
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.